{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:16:45Z","timestamp":1767169005401,"version":"build-2238731810"},"reference-count":25,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computational and Mathematical Methods in Medicine"],"published-print":{"date-parts":[[2022,6,30]]},"abstract":"<jats:p>\n                    Purpose. This study was aimed at demonstrating the role of rituximab (RTX) on the influence of nephrotic syndrome (NS) and on urinary protein which was not significant. Methods. The clinical randomized controlled trials were performed by eight databases. Meanwhile, the confidence interval (CI) of either relative risk or mean difference was set to 95%. Besides, the heterogeneity of the research results is tested by\n                    <jats:inline-formula>\n                      <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:msup>\n                          <a:mrow>\n                            <a:mi>I<\/a:mi>\n                          <\/a:mrow>\n                          <a:mrow>\n                            <a:mn>2<\/a:mn>\n                          <\/a:mrow>\n                        <\/a:msup>\n                      <\/a:math>\n                    <\/jats:inline-formula>\n                    . Results. A total of 1658 references were found using the search method. This meta-analysis will be done by the ultimately eight different studies. Each study is described as random controlled trial. According to these eight studies, the remission of test group and control group was quite higher (OR: 1.60; 95% Cl: 1.17, 2.20;\n                    <jats:inline-formula>\n                      <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                        <c:mo>&lt;<\/c:mo>\n                        <c:mn>0.01<\/c:mn>\n                      <\/c:math>\n                    <\/jats:inline-formula>\n                    ) than the control group, serum albumin (SMD: 4.19; 95% Cl: 1.49, 6.89;\n                    <jats:inline-formula>\n                      <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>&lt;<\/e:mo>\n                        <e:mn>0.01<\/e:mn>\n                      <\/e:math>\n                    <\/jats:inline-formula>\n                    ), and urine protein (SMD: 0.79; 95% Cl: -0.64, 2.22;\n                    <jats:inline-formula>\n                      <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>=<\/g:mo>\n                        <g:mn>0.28<\/g:mn>\n                      <\/g:math>\n                    <\/jats:inline-formula>\n                    ). Despite the fact that the remission rate\u2019s funnel plot was asymmetrically distributed, Egger\u2019s test and Begg\u2019s test revealed no probable publish bias. Conclusion. The results of this study suggest that rituximab (RTX) may be effective in RNS, as evidenced by remission rates and serum albumin. However, the effect on urinary protein was not significant. The clear evidence is missing in this literature. Therefore, large sample, multicenter, low risk of bias clinical studies, as well as basic medical research, is needed.\n                  <\/jats:p>","DOI":"10.1155\/2022\/3008597","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T16:35:39Z","timestamp":1656606939000},"page":"1-8","source":"Crossref","is-referenced-by-count":1,"title":["Rituximab May Have Positive Effect on Refractory Nephrotic Syndrome: A Meta-Analysis of Randomized Trials"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-5361","authenticated-orcid":true,"given":"Jingjing","family":"Lin","sequence":"first","affiliation":[{"name":"Nephrology Department, First People\u2019s Hospital of Linping District, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[{"name":"Nephrology Department, First People\u2019s Hospital of Linping District, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.280"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/74166"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200107000-00009"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2245491"},{"issue":"1","key":"5","first-page":"1","article-title":"Management strategy for idiopathic nehprotic syndrome in children","volume":"33","author":"M. C. Chiu","year":"2008","journal-title":"Zhong Nan Da Xue Xue Bao. Yi Xue Ban"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199701000-00004"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.03.002"},{"issue":"6","key":"8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","article-title":"Primary focal segmental glomerulosclerosis: clinical course and response to therapy","volume":"23","author":"S. M. Korbet","year":"2022","journal-title":"American Journal of Kidney Diseases"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(16)34218-3"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1981.209"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05691108"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.09.012"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008070786"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1434-z"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016040449"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013157"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014080799"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09421010"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.1323"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60541-9"},{"issue":"8","key":"21","first-page":"961","article-title":"Clinical analysis of rituximab combined with hormone sequential therapy in the treatment of refractory microscopic nephrotic syndrome","volume":"32","author":"Y. Fengliang","year":"2020","journal-title":"Modern Practical Medicine"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011080775"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91880-7"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.10.1639"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1002\/art.20858"}],"updated-by":[{"DOI":"10.1155\/2023\/9758494","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"record-id":"61535"},{"DOI":"10.1155\/2023\/9758494","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000}}],"container-title":["Computational and Mathematical Methods in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/3008597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/3008597.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/3008597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T16:35:45Z","timestamp":1656606945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/cmmm\/2022\/3008597\/"}},"subtitle":[],"editor":[{"given":"Ahmed Faeq","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":25,"alternative-id":["3008597","3008597"],"URL":"https:\/\/doi.org\/10.1155\/2022\/3008597","relation":{},"ISSN":["1748-6718","1748-670X"],"issn-type":[{"value":"1748-6718","type":"electronic"},{"value":"1748-670X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}